Shots: Bain Capital and Cinven to acquire Lonza’s specialty ingredients business and operations for an enterprise value of $4.7B. The transaction is expected to close in H2’21 The divestiture will […]readmore
Tags : Specialty
Shots: Boston Scientific signs an agreement with Stark International and SERB SAS to sell its BTG specialty pharma business for $800M in cash. The transaction is expected to close in […]readmore
Shots: Innovate to acquire all outstanding shares of RDD in exchange for a combination of common and preferred shares and create a new Nasdaq listed company. Following the closing of […]readmore